阿普塔默的应用和肝脏疾病的研究进展
Cheng Xu1,2,3, Yong Tan4, Li-Ye Zhang1,2,3
1Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, China Three Gorges University, Yichang, China.
Molecular biotechnology
|February 2, 2024
概括
亚胺或核酸亚胺在诊断和治疗肝病方面表现有前途,因为它们比抗体具有优势. 需要进一步的研究来优化其开发和应用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 生物技术是生物技术.
背景情况:
- 亚胺是小核酸分子,与抗体相比具有优势,包括更低的成本和免疫性.
- 目前的应用包括疾病生物标志物发现,诊断,治疗和药物输送.
- 仍然存在的挑战在于阿帕特默查,优化,稳定性和毒性.
研究的目的:
- 审查aptamer在疾病诊断和治疗中的应用现状.
- 突出阿普坦在治疗肝脏疾病方面的特殊潜力.
- 通过使用计算工具来探索aptamer-target的相互作用.
主要方法:
- 在疾病诊断和治疗中对阿巴胺应用的文献综述.
- 在肝脏疾病的背景下,专注于体.
- 使用Discovery Studio软件进行目标识别和交互分析.
主要成果:
- 亚胺为肝脏疾病的诊断和治疗提供了显著的潜力.
- 发现工作室有助于识别aptamer结合目标和相互作用地点.
- 优化亚胺体查和开发至关重要.
结论:
- 胺剂是促进肝病诊断和治疗的宝贵工具.
- 像发现工作室这样的计算方法对于aptamer开发至关重要.
- 解决阿普坦酶优化方面的挑战将提高它们的临床实用性.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121


